MINA Antibody

CAT:
223-5617-01
Size:
0.02 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
MINA Antibody - image 1

MINA Antibody

  • Background:

    MINA Antibody: MINA is nuclear localized, myc-inducible protein that is thought to play a role in mammalian cell proliferation. Treatment of cancer cells lines such as the colon cancer cell line SW680 with siRNA against MINA inhibits cell growth, demonstrating that MINA may be a potential therapeutic target. MINA regulates several genes related to cell adhesion and metabolism that have also been shown to be regulated by c-Myc, but also regulates other genes whose expression are not modulated by c-Myc such as EGFR, IL-6 and HGF. MINA has also been found to act as a repressor to IL-4 expression in T cells, indicating that it may also play a role in T cell differentiation and genetic variation in T helper type 2 bias.
  • NCBI Gene ID:

    84864
  • Swiss Prot:

    Q8IUF8
  • Accession Number:

    NP_694822
  • Host:

    Rabbit
  • Reactivity:

    Human, Mouse
  • Clonality:

    Polyclonal
  • Conjugation:

    Unconjugated
  • Type:

    Primary Antibodies
  • Field of Research:

    Cancer, Cell Cycle
  • Purification:

    MINA Antibody is affinity chromatography purified via peptide column.
  • Positive Control:

    Cat. No. 1301 - Human Heart Tissue Lysate
  • Concentration:

    1 mg/mL
  • Homology:

    Predicted species reactivity based on immunogen sequence: Bovine: (80%), Rat: (80%)
  • Buffer:

    MINA Antibody is supplied in PBS containing 0.02% sodium azide.
  • Modification:

    None
  • Shipping Conditions:

    Blue Ice
  • Storage Conditions:

    MINA antibody can be stored at 4˚ C for three months and -20˚ C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
  • Fragment:

    IgG
  • Symbol:

    MINA
  • NCBI Official Name:

    MYC induced nuclear antigen
  • NCBI Organism:

    Homo sapiens
  • Background Reference 01:

    Tsuneoka M, Kody Y, Soejima M, et al. A novel myc target gene, mina53, that is involved in cell proliferation. J. Biol. Chem.2002; 277:35450-9.
  • Background Reference 02:

    Teye K, Tsuneoka M, Arima N, et al. Increased expression of a Myc target gene Mina53 in human colon cancer. Am. J. Pathol.2004; 164:205-16.
  • Background Reference 03:

    Komiya K, Sueoka-Aragane N, Sato A, et al. Mina53, a novel c-Myc target gene, is frequently expressed in lung cancers and exerts oncogenic property in NIH/3T3 cells. J. Cancer Res. Clin. Oncol.2010; 136:465-73.
  • Background Reference 04:

    Okamoto M, Van Stry M, Chung L, et al. Mina, an IL4 repressor, controls T helper type 2 bias. Nat. Immunol.2009; 10:872-9.
  • Other Product Names:

    MINA Antibody: ROX, MDIG, NO52, MINA53, Bifunctional lysine-specific demethylase and histidyl-hydroxylase MINA, 60S ribosomal protein L27a histidine hydroxylase, ROX
  • Tested Applications:

    ELISA, WB, IHC-P, IF
  • Protein ID:

    110227621
  • Physical Properties:

    Liquid